Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

Amy L. Sherborne, Fay J. Hosking, Rashmi B. Prasad, Rajiv Kumar, Rolf Koehler, Jayaram Vijayakrishnan, Elli Papaemmanuil, Claus R. Bartram, Martin Stanulla, Martin Schrappe, Andreas Gast, Sara E. Dobbins, Yussanne Ma, Eamonn Sheridan, Malcolm Taylor, Sally E. Kinsey, Tracey Lightfoot, Eve Roman, Julie A.E. Irving, James M. AllanAnthony V. Moorman, Christine J. Harrison, Ian P. Tomlinson, Sue Richards, Martin Zimmermann, Csaba Szalai, Ågnes F. Semsei, Daniel J. Erdelyi, Maja Krajinovic, Daniel Sinnett, Jasmine Healy, Anna Gonzalez Neira, Norihiko Kawamata, Seishi Ogawa, H. Phillip Koeffler, Kari Hemminki, Mel Greaves, Richard S. Houlston

Research output: Contribution to journal › Article › peer-review

192 Scopus citations

Fingerprint

Dive into the research topics of 'Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk'. Together they form a unique fingerprint.

Medicine & Life Sciences